Article Information
History
- September 18, 2021.
Article Versions
- Version 1 (September 14, 2021 - 11:49).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Alberto Cedro-Tanda1,+,
- Laura Gómez-Romero1,+,
- Nicolás Alcaraz1,
- Guillermo de Anda-Jauregui1,
- Fernando Peñaloza1,
- Bernardo Moreno1,
- Marco A. Escobar-Arrazola5,
- Oscar A. Ramirez-Vega5,
- Paulina Munguia-Garza5,
- Francisco Garcia-Cardenes1,
- Mireya Cisneros-Villanueva1,
- Jose L. Moreno-Camacho7,
- Jorge Rodriguez-Gallegos7,8,
- Marco A. Luna-Ruiz Esparza6,
- Miguel A. Fernández Rojas6,
- Alfredo Mendoza-Vargas1,
- Juan Pablo Reyes-Grajeda1,
- Abraham Campos-Romero6,
- Ofelia Angulo2,
- Rosaura Ruiz2,
- Claudia Sheinbaum3,
- José Sifuentes-Osornio4,
- David Kershenobich4,
- Alfredo Hidalgo-Miranda1,* and
- Luis A. Herrera1,5,*
- 1Instituto Nacional de Medicina Genómica, INMEGEN, Mexico City, Mexico
- 2Secretaría de Educación, Ciencia, Tecnología e Innovacion, Mexico City, Mexico
- 3Gobierno de la Ciudad de México
- 4Instituto Nacional de Ciencias Médicas y Nutrición Salvadro Zubirán, Mexico City, Mexico
- 5Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, UNAM, Mexico City, Mexico
- 6Innovation and Research Department, Salud Digna, Culiacan, 80000, Sinaloa, Mexico
- 7Clinical Laboratory Division, Salud Digna, Culiacan, 80000, Sinaloa, Mexico
- 8Molecular Biology Laboratory, National Reference Center, Salud Digna, Tlalnepantla de Baz, 54075, Estado de Mexico, Mexico
- ↵*Corresponding authors: LAH: lherrera{at}inmegen.gob.mx; AHM: ahidalgo{at}inmegen.gob.mx
Posted September 18, 2021.
The evolutionary landscape of SARS-CoV-2 variant B.1.1.519 and its clinical impact in Mexico City
